Hermetica Superfood Encyclopedia
The Short Answer
Gymnopilus spectabilis, commonly known as the "Laughing Gym," is a psychoactive mushroom primarily containing psilocin. Psilocin acts as a hallucinogen by mimicking serotonin in the brain, leading to altered perception and mood changes.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelModerate
Primary Keywordgymnopilus spectabilis benefits
Synergy Pairings4
Gymnopilus Spectabilis — botanical close-up
Health Benefits
Enhances neuroplasticity, potentially aiding in memory and learning through the action of psilocybin.
May alleviate symptoms of depression and anxiety by influencing serotonin pathways in the brain.
Facilitates introspection and emotional processing, potentially reducing stress and enhancing mental clarity.
Bioactive compounds may exhibit anti-inflammatory properties, though further research is required.
Traditionally used in ceremonies to enhance spiritual insight and connection
Origin & History
Natural habitat
*Gymnopilus spectabilis*, commonly known as the "Laughing Gym," is a large, golden-orange mushroom found on decaying wood in temperate forests. It is primarily known for its psychoactive properties, attributed to the presence of psilocybin and psilocin. This species holds historical significance in certain traditional practices and is currently explored in modern research for its potential to influence mood, perception, and cognition.
“*Gymnopilus spectabilis* has historical significance in certain traditional practices and spiritual ceremonies, where its psychoactive properties were believed to facilitate deep introspection and connection. Its use was often guided by shamans or healers to influence perception and cognition for spiritual growth.”Traditional Medicine
Scientific Research
Research into *Gymnopilus spectabilis* primarily focuses on the psychoactive compounds psilocybin and psilocin, with emerging studies exploring their potential in neuroplasticity and mood regulation. While preliminary findings suggest therapeutic applications in psychedelic-assisted therapy, its use requires significant caution due to variability in potency and effects, and is subject to legal restrictions.
Preparation & Dosage
Traditional preparation
Common forms
Dried powder or tea.
Preparation
Steep dried mushrooms in hot water for 15–20 minutes to make tea.
Dosage
Varies significantly; microdoses (0.1–0.3 grams) for potential therapeutic benefits, higher doses for psychoactive experiences.
Contraindications
Must be consumed under appropriate guidance and in a safe environment due to variable potency and psychoactive effects.
Nutritional Profile
- Psilocybin: Psychoactive compound influencing serotonin receptors, linked to cognitive and emotional effects.
- Psilocin: Active psychoactive metabolite of psilocybin.
- Alkaloids: Additional bioactive compounds contributing to its unique pharmacological profile.
How It Works
Mechanism of Action
The primary psychoactive compound in Gymnopilus spectabilis is psilocin, which functions as a hallucinogen by acting as a partial agonist at various serotonin receptors in the brain, particularly the 5-HT2A receptor. By mimicking serotonin, psilocin alters neuronal activity, leading to changes in perception, mood, and thought processes, characteristic of its hallucinogenic effects. Psilocybin, a precursor to psilocin, is typically absent or present in minimal concentrations in this species.
Clinical Evidence
There are currently no human clinical trials specifically investigating the effects, safety, or therapeutic potential of Gymnopilus spectabilis. Research to date primarily focuses on its chemical composition, identifying psilocin as the main psychoactive compound, with psilocybin being minimal or absent. Consequently, there is no scientific evidence from controlled studies to support claims of neuroplasticity enhancement or alleviation of depression and anxiety directly attributable to Gymnopilus spectabilis consumption. Its reported psychoactive effects are based solely on anecdotal accounts.
Safety & Interactions
Due to the presence of psilocin, ingestion of Gymnopilus spectabilis can cause significant and unpredictable psychoactive effects, including visual and auditory hallucinations, mood swings, anxiety, paranoia, and disorientation. As there are no human clinical trials, specific drug interactions are not documented, but caution is highly advised with other serotonergic drugs (e.g., antidepressants, MAOIs) due to the theoretical risk of serotonin syndrome. Its use is contraindicated in individuals with pre-existing psychiatric conditions, pregnant or breastfeeding women, and those with a history of psychosis, given the potential for severe psychological reactions. Furthermore, misidentification with other toxic mushroom species poses a serious risk.
Synergy Stack
Hermetica Formulation Heuristic
Myco-adaptogenic base
Mood & Stress | Cognition & Focus
Also Known As
Gymnopilus junoniusGymnopilus subspectabilisLaughing Gym
Frequently Asked Questions
What are the primary psychoactive compounds in Gymnopilus spectabilis?
The main psychoactive compound found in Gymnopilus spectabilis is psilocin, which acts as a hallucinogen by mimicking serotonin in the brain. Unlike some other psychoactive mushrooms, psilocybin itself is typically absent or present in only minimal amounts in this species.
What kind of effects does Gymnopilus spectabilis produce?
Ingesting Gymnopilus spectabilis can lead to hallucinogenic effects such as visual distortions, heightened color perception, feelings of hilarity, significant mood swings, and general hallucinations. These effects are mediated by psilocin's action on serotonin pathways.
Is Gymnopilus spectabilis used for health benefits like neuroplasticity or mood regulation?
While psilocybin (notably distinct from the psilocin dominant in G. spectabilis) is being researched for therapeutic uses, there is no scientific or clinical evidence to support claims that Gymnopilus spectabilis itself enhances neuroplasticity or alleviates depression and anxiety. Its use is primarily recreational for its hallucinogenic properties.
Are there any clinical studies on Gymnopilus spectabilis?
Currently, there are no human clinical trials or controlled studies investigating the specific effects, safety, or potential therapeutic applications of Gymnopilus spectabilis. Research is limited to chemical analysis and anecdotal reports of its psychoactive properties.
What are the risks associated with consuming Gymnopilus spectabilis?
Risks include unpredictable and potentially severe psychological effects like anxiety, paranoia, and psychosis, especially in susceptible individuals. There's also a significant risk of misidentification with other toxic mushrooms, and specific drug interactions are unknown, making its consumption highly risky.
How much Gymnopilus spectabilis should I take and what is a safe dosage range?
Dosage for Gymnopilus spectabilis varies widely depending on the form and individual sensitivity, with typical ranges reported between 1-5 grams of dried fruiting body, though some sources cite higher amounts. Since psilocybin content can be highly variable between specimens and growing conditions, standardized extracts or lab-tested materials are recommended to ensure consistent dosing. Onset typically occurs within 30-90 minutes when ingested, with effects lasting 4-6 hours. Due to the lack of regulated dosing standards and the legal status of psilocybin in most jurisdictions, consultation with experienced practitioners in legal contexts is essential.
Does Gymnopilus spectabilis interact with antidepressants, SSRIs, or other common medications?
Gymnopilus spectabilis contains psilocybin, which acts on serotonin receptors and may interact with SSRIs and other serotonergic medications, potentially increasing the risk of serotonin syndrome in some cases. Concurrent use with MAO inhibitors, tricyclic antidepressants, or other psychoactive substances may produce unpredictable effects and is generally contraindicated. The mushroom may also interact with medications metabolized by cytochrome P450 enzymes, though research on specific interactions remains limited. Anyone taking prescription medications should avoid use or consult a healthcare provider in jurisdictions where such consultation is legally possible.
Who should avoid Gymnopilus spectabilis and is it safe for people with certain health conditions?
Individuals with a personal or family history of schizophrenia, bipolar disorder, or other psychotic conditions should avoid Gymnopilus spectabilis, as psilocybin may exacerbate these conditions. People with uncontrolled hypertension, heart disease, or severe anxiety disorders should exercise caution, as the mushroom can increase heart rate and blood pressure temporarily. Pregnant and breastfeeding individuals should avoid use due to insufficient safety data and potential effects on fetal development. Those with liver or kidney impairment may have altered metabolism of psilocybin and should avoid consumption.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w gymnopilus-spectabilis curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
